Most of the WWB discussion here is about GLP-1 agonists, but they've been expanding their peptide catalog. I recently ordered their BPC-157 and TB-500 (Thymosin Beta-4 fragment) for a healing stack and wanted to share my experience and test results. Order Details: - 10x BPC-157 5mg vials — $12/vial - 5x TB-500 5mg vials — $18/vial - Total: $210 + $25 shipping = $235 - Payment: USDT (TRC-20) - Shipped Feb 5, 2026. Arrived Feb 19 (14 days to Southeast US) Janoshik Testing: - BPC-157: 98.8% purity (HPLC). Clean certificate, no significant impurity peaks. - TB-500: 97.6% purity (HPLC). One minor impurity at 1.4%, identified as a truncated fragment. For context, BPC-157 is a relatively simple 15-amino-acid peptide, so high purity is expected. TB-500 is a 43-amino-acid fragment of thymosin beta-4 — more complex to synthesize, so 97.6% is respectable. Protocol I'm Running: - BPC-157: 250mcg 2x daily (morning and evening), subcutaneous near injury site - TB-500: 2.5mg 2x per week, subcutaneous - Purpose: recovering from a partially torn rotator cuff (confirmed via MRI, not surgical candidate per ortho) Results after 3 weeks: - Pain reduced from 7/10 to 4/10 - Range of motion improved noticeably — can reach overhead again without sharp pain - Sleep quality improved (unexpected bonus, possibly BPC-157 related) - No side effects noted I know healing stacks are controversial and the evidence is mostly preclinical, but subjectively this is working for me. The quality from WWB seems on par with what I was getting from a US research chem company that shut down last year, at literally 1/3 the price.

The BPC-157 purity is solid. 98.8% for a pentadecapeptide is what you'd expect from a competent synthesis operation. The TB-500 at 97.6% is also reasonable — I've seen it range from 94-98% across various Chinese sources. One note on your protocol: the evidence for "inject near injury site" with BPC-157 is actually pretty weak. The original Sikiric lab research used IP (intraperitoneal) injection in rodents, not local injection. The peptide is systemically active — it doesn't need to be local. Some practitioners argue subcutaneous in the abdomen is just as effective for a shoulder injury. Might save you some awkward self-injection sessions. That said, if it's working, don't change it. N=1 and all that.

Interesting point about injection site. I started local because that's what most protocols online recommend, but I've been doing my evening dose in the abdomen for convenience and honestly haven't noticed a difference in efficacy. Maybe I'll switch entirely to abdominal subQ. Worth noting the injection volumes are tiny — 250mcg from a 5mg/2mL reconstitution is only 0.1mL. Easy injection regardless of site.

Good to see WWB's non-GLP-1 products getting tested. I ordered their GHK-Cu (copper peptide) and Ipamorelin last month. Haven't sent to Janoshik yet but the GHK-Cu reconstituted with the expected blue-green tint from the copper complex, which at least tells me there's actual copper peptide in there. Prices for reference: - GHK-Cu 50mg: $22/vial - Ipamorelin 5mg: $14/vial Both significantly cheaper than US research chem sites (when they existed). The grey market is basically the only game in town for research peptides now thanks to FDA enforcement actions.

How are you storing the reconstituted BPC-157? It's notoriously fragile — the pentadecapeptide bond is susceptible to oxidation, especially in solution. Some people add a tiny amount of ascorbic acid to the BAC water to prevent degradation but that's debatable. Also, at 250mcg 2x/day, a 5mg vial lasts 10 days. Are you going through a vial every 10 days? That's $36/month in BPC alone. Not bad honestly.